Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

AdVance® vs ARGUS® Sling Procedure in Male With Post Prostatectomy Stress Urinary Incontinence

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2013 by Jacques Corcos, Jewish General Hospital.
Recruitment status was:  Recruiting
Center Hospitalier de Fleurimont,Sherbrooke University
Sunnybrook Health Sciences Centre
Information provided by (Responsible Party):
Jacques Corcos, Jewish General Hospital Identifier:
First received: May 28, 2013
Last updated: May 30, 2013
Last verified: May 2013
The study is designed to assess efficacy and subject satisfaction of two sling devices: Advance and Argus, in male patients with stress urinary incontinence after prostatectomy.

Condition Intervention
Stress Urinary Incontinence
Procedure: AdVance® sling procedure
Procedure: ARGUS Sling procedure

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Participant)
Primary Purpose: Treatment
Official Title: Randomised Clinical Trial to Evaluate Efficacy of AdVance® vs ARGUS® Sling Procedure in Male With Post Prostatectomy Stress Urinary Incontinence

Resource links provided by NLM:

Further study details as provided by Jacques Corcos, Jewish General Hospital:

Primary Outcome Measures:
  • Patient satisfaction using the Patient Global Impression of Improvement (PGI-I) score and assess change in 24-hour pad weight . [ Time Frame: 12 months ]

Secondary Outcome Measures:
  • Assess change in subject satisfaction using questionnaires: ICIQ, UCLA-RAND Incontinence Index. [ Time Frame: 12 months ]

Other Outcome Measures:
  • Summarize all cumulative device and procedure related adverse events [ Time Frame: 12 months ]

Estimated Enrollment: 128
Study Start Date: June 2012
Estimated Study Completion Date: June 2015
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: AdVance
sling procedure
Procedure: AdVance® sling procedure
Active Comparator: ARGUS
sling procedure
Procedure: ARGUS Sling procedure


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • The subject is male
  • The subject is at least 18 years of age
  • The subject has an estimated life expectancy of more than 5 years
  • The subject has confirmed stress urinary incontinence (SUI) through medical history, urodynamics, and/or physical exam for at least 6 months
  • The subject has intrinsic sphincter deficiency due to one of the following:

post-TURP, simple open prostatectomy, radical prostatectomy completed at least 6 months prior to implantation date

  • Positive Cough Stress Test (CST):
  • Positive 24-hours Pad Test (PT):

A positive PT is confirmed with leakage of >8.O g/24h and < 400 g

  • The subject has completed urodynamics, uroflow, post-void residual, and cystoscopy as per the protocol within 6 months prior to implant
  • The subject is able and willing to complete all follow-up visits and procedures indicated in this protocol
  • The subject has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as approved by the local ethics commit-tee of the respective site

Exclusion Criteria:

  • Subjects who meet any of the following criteria are excluded from entry into the study
  • The subject is unable or unwilling to sign the Informed Consent Form (ICF) and/or comply with all follow-up requirements according to the study protocol
  • The subject has an active urogenital infection or active skin infection in region of surgery
  • The subject has serious bleeding disorders
  • The subject has incontinence due to neurogenic causes defined as multiple sclerosis, spinal cord/brain injury, CVA, detrusor-external sphincter dyssynergia, Parkinson's disease, or similar conditions
  • The subject had a previous implant to treat stress urinary incontinence
  • The subject has undergone radiation, cryosurgery, or brachy therapy to treat prostate or other pelvic cancer within 6 months
  • The subject is likely to undergo radiation therapy within the next 6 months
  • The subject has active urethral or bladder neck stricture disease, requiring continued treatment
  • The subject has urge predominant incontinence
  • The subject has an atonic bladder or a postvoid residual (PVR) ≥150mL
  • The subject has a condition or disorder likely to require future transurethral procedure
  • The subject is enrolled in a concurrent clinical trial of any treatment (drug or device) that could affect continence function without the sponsors'approval
  • Subjects who in the opinion of the investigator are unable and/or unlikely to to comprehend the nature, scope and possible consequences of the study and to follow the study procedures and instructions and complete all study related measurements.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01866085

Contact: Jacques Corcos, MD 1-514-340-8222 ext 5166
Contact: Oleg Loutochin 1-514-340-8222 ext 1627

Canada, Quebec
Jewish General Hospital Recruiting
Montreal, Quebec, Canada, H3T 1E2
Contact: Jacques Corcos, MD    1-514-340-8222 ext 5166   
Contact    1-514-340-8222 ext 1627   
Principal Investigator: Jacques Corcos, MD         
Sponsors and Collaborators
Jewish General Hospital
Center Hospitalier de Fleurimont,Sherbrooke University
Sunnybrook Health Sciences Centre
  More Information

Responsible Party: Jacques Corcos, MD. Professor of Urology, McGill University, Jewish General Hospital Identifier: NCT01866085     History of Changes
Other Study ID Numbers: 12-013
12-013 ( Other Identifier: Research Ethics Board,JGH )
Study First Received: May 28, 2013
Last Updated: May 30, 2013

Keywords provided by Jacques Corcos, Jewish General Hospital:
stress urinary incontinence
post prostatectomy

Additional relevant MeSH terms:
Urinary Incontinence
Urinary Incontinence, Stress
Urination Disorders
Urologic Diseases
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms
Behavioral Symptoms
Elimination Disorders
Mental Disorders processed this record on May 25, 2017